Lixia Xu
- Nephrology top 5%
- Renal Diseases and Glomerulopathies 6
- Acute Kidney Injury Research 3
-
- Blood Pressure and Hypertension Studies 2
- Heart Failure Treatment and Management 2
-
- Cancer-related molecular mechanisms research 3
-
- Nutritional Studies and Diet 2
-
- Reproductive System and Pregnancy 2
-
- Nanoplatforms for cancer theranostics 2
- Journals
- Nature Communications (1 paper)SHILAP Revista de lepidopterología (1 paper)PLoS ONE (3 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Lixia Xu
33 papers receiving 570 citations
Peers
Comparison fields: 5 of 106
- Nephrology 98
- Cardiology and Cardiovascular Medicine 172
- Speech and Hearing 24
- Cancer Research 44
- Pulmonary and Respiratory Medicine 95
Countries citing papers authored by Lixia Xu
This map shows the geographic impact of Lixia Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lixia Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lixia Xu more than expected).
Fields of papers citing papers by Lixia Xu
This network shows the impact of papers produced by Lixia Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lixia Xu. The network helps show where Lixia Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lixia Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 1 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 5 | |
| 7 | 2023 | 29 | |
| 8 | 2023 | 7 | |
| 9 | 2023 | 3 | |
| 10 | 2022 | 24 | |
| 11 | 2022 | 8 | |
| 12 | 2020 | 40 | |
| 13 | 2020 | 3 | |
| 14 | 2015 | 6 | |
| 15 | 2014 | 7 | |
| 16 | 2013 | 16 | |
| 17 | 2013 | 31 | |
| 18 | 2012 | 19 | |
| 19 | 2011 | 82 | |
| 20 | 2010 | 11 |
About Lixia Xu
Lixia Xu is a scholar working on Nephrology, Applied Microbiology and Biotechnology and Critical Care and Intensive Care Medicine, having authored 35 papers that have together received 586 indexed citations. Recurring topics across this work include Renal Diseases and Glomerulopathies (6 papers), Cancer-related molecular mechanisms research (3 papers), Acute Kidney Injury Research (3 papers), Nutritional Studies and Diet (2 papers), Blood Pressure and Hypertension Studies (2 papers), Reproductive System and Pregnancy (2 papers), Heart Failure Treatment and Management (2 papers) and Nanoplatforms for cancer theranostics (2 papers). The work is most often cited by research in Nephrology (98 citations), Cardiology and Cardiovascular Medicine (172 citations) and Speech and Hearing (24 citations). Lixia Xu has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Shuangxin Liu, Xinling Liang, Wenjian Wang, Qiao Lin, Guang‐Hui Dong, Da Wang, Miao Liu, Shen Tian, Zhilian Li and Jianchao Ma. Their work appears in journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.